Menotropins vs hcg

Menotropins (S-tier) vs hcg (S-tier). mechanism, trials, evidence boundaries, dosing literature. side-by-side reference.

Menotropins · tier S

Current US Menopur is a subcutaneous urinary menotropins product for developing multiple follicles and pregnancy in ovulatory women during an ART cycle. It is fertility medicine, not sexual-performance or hormone-optimization treatment.

Monitored ART trials support Menopur's current female indication and quantify pregnancy, live-birth, OHSS, and multiple-pregnancy outcomes. Historical male hMG plus hCG findings do not create a current Menopur male indication or regimen.

50.6% vs 51.5% cumulative live birth in MEGASET-HR · half-life 11 to 13 h for FSH activity after multiple SC or IM exposure in suppressed women · libido

hcg · tier S

A placental glycoprotein hormone that activates the LH receptor. Product form and labeled route matter.

HCG has established fertility and selected male endocrine uses. Small human studies support intratesticular-testosterone and semen preservation during testosterone therapy, but that adjunct use remains off-label. HCG does not cause weight loss.

32 to 33 h terminal half-life in an 18-woman Pregnyl crossover · half-life 32 to 33 hours in one Pregnyl IM and SC crossover · libido

at a glance

• Menotropins: tier S · 50.6% vs 51.5% cumulative live birth in MEGASET-HR
• hcg: tier S · 32 to 33 h terminal half-life in an 18-woman Pregnyl crossover

reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.